| Line item | 2026-01-31 FY | 2025-02-01 FY | 2024-02-03 FY | 2023-01-28 FY | 2022-01-29 FY | 2021-01-30 FY |
|---|---|---|---|---|---|---|
| Revenue | $147.64B | $147.12B | $150.04B | $148.26B | $137.89B | $132.50B |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | $1.89B | $3.85B | $3.10B | $4.13B | $3.48B | $2.78B |
| Interest Expense | – | – | $441.00M | $535.00M | $571.00M | $544.00M |
| Tax Expense | $176.00M | $670.00M | $667.00M | $653.00M | $385.00M | $782.00M |
| Net Income | $1.02B | $2.67B | $2.16B | $2.24B | $1.66B | $2.58B |
| EPS (basic) | 1.5500 | 3.7000 | 2.9900 | 3.1000 | 2.2000 | 3.3100 |
| EPS (diluted) | 1.5400 | 3.6700 | 2.9600 | 3.0600 | 2.1700 | 3.2700 |
| Shares (diluted) | $655.00M | $720.00M | $725.00M | $727.00M | $754.00M | $781.00M |